These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9037627)

  • 21. Prevention of cytomegalovirus disease.
    Bailey TC
    Semin Respir Infect; 1993 Sep; 8(3):225-32. PubMed ID: 8016483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and treatment of cytomegalovirus infections in solid organ transplant recipients.
    Danziger-Isakov LA; Storch GA
    Pediatr Infect Dis J; 2002 May; 21(5):432-4. PubMed ID: 12150182
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytomegalovirus infection in transplant recipients].
    Gondo H
    Nihon Rinsho; 1998 Jan; 56(1):173-8. PubMed ID: 9465685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of cytomegalovirus disease in solid organ transplant recipients: the clinical and economic impact of evolving strategies. Introduction.
    Pescovitz MD
    Am J Health Syst Pharm; 2003 Dec; 60(23 Suppl 8):S3-4. PubMed ID: 14686227
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytomegalovirus infections in transplant patients].
    Charpentier B
    Presse Med; 1991 Jun; 20(24):1107-8. PubMed ID: 1649473
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytomegalovirus disease in transplant recipients.
    Faoagali JL
    N Z Med J; 1994 Jan; 107(970):18. PubMed ID: 8295749
    [No Abstract]   [Full Text] [Related]  

  • 27. A cytomegalovirus vaccine for transplantation: are we closer?
    Go V; Pollard RB
    J Infect Dis; 2008 Jun; 197(12):1631-3. PubMed ID: 18444884
    [No Abstract]   [Full Text] [Related]  

  • 28. Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients.
    Fishman JA; Doran MT; Volpicelli SA; Cosimi AB; Flood JG; Rubin RH
    Transplantation; 2000 Feb; 69(3):389-94. PubMed ID: 10706048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis and treatment of CMV infections in transplantation.
    Zaia JA
    Adv Exp Med Biol; 1996; 394():117-34. PubMed ID: 8815679
    [No Abstract]   [Full Text] [Related]  

  • 30. Delayed onset CMV disease in solid organ transplant recipients.
    Husain S; Pietrangeli CE; Zeevi A
    Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Torres-Madriz G; Boucher HW
    Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients.
    Koval CE
    Infect Dis Clin North Am; 2018 Sep; 32(3):581-597. PubMed ID: 30146024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.
    Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Danziger-Isakov L; Humar A;
    Transplantation; 2013 Aug; 96(4):333-60. PubMed ID: 23896556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus pneumonia in transplant recipients.
    Ison MG; Fishman JA
    Clin Chest Med; 2005 Dec; 26(4):691-705, viii. PubMed ID: 16263406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Pescovitz MD
    Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus infections in transplant patients.
    Ljungman P
    Scand J Infect Dis Suppl; 1996; 100():59-63. PubMed ID: 8860355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of cytomegalovirus disease in transplant recipients.
    Snydman DR; Falagas ME
    Lancet; 1996 Jan; 347(8996):268-9. PubMed ID: 8551918
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.
    Boivin G; Goyette N; Gilbert C; Humar A; Covington E
    Transpl Infect Dis; 2005; 7(3-4):166-70. PubMed ID: 16390409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of cytomegalovirus pneumonia in transplant patients.
    Reed EC
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):8-12. PubMed ID: 1647562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.